The UK vedolizumab real-life experience study in inflammatory bowel disease (VEST): patient characteristics, drug persistence and patient-centred outcomes
Therapeutic Advances in Gastroenterology
Published online on May 31, 2026
Abstract
Therapeutic Advances in Gastroenterology, Volume 19, January-December 2026.
Background:VEST was a multi-centre study of real-world use of vedolizumab in inflammatory bowel disease (IBD) in routine practice in the United Kingdom.Objectives:To describe real-world indications, effectiveness, patient-reported outcomes and safety....
Background:VEST was a multi-centre study of real-world use of vedolizumab in inflammatory bowel disease (IBD) in routine practice in the United Kingdom.Objectives:To describe real-world indications, effectiveness, patient-reported outcomes and safety....